ECLP Eclipsys Corp. (MM)

Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®, today announced that Camden-Clark Memorial Hospital (Camden-Clark), a 273-bed community hospital located in Parkersburg, WV, has signed a multimillion dollar agreement to support clinical excellence and business transformation goals. New client Camden-Clark will pursue becoming a top performing hospital by replacing legacy competitor technology with the entire Sunrise Enterprise™ integrated suite of clinical and revenue cycle solutions, along with Eclipsys’ Enterprise Performance Management solution suite. Once complete, the sweeping electronic health record (EHR) and administrative software initiative will serve to improve care team efficiency, clinical decision making, while enhancing administrative processes, patient safety and throughput. The community hospital also will be positioned to achieve the expected “Meaningful Use” requirements of the American Reinvestment and Recovery Act (ARRA) of 2009. To that end, Camden-Clark will use Eclipsys’ “speed to value” implementation approach to accelerate the activation timeframe to help meet the specified timeline requirements of ARRA in order to maximize stimulus payment opportunities.

Achieving ARRA Guidelines and Improving Outcomes across the Care Continuum

“Our hospital chose Eclipsys because they share our vision to achieve top decile performance in patient quality and satisfaction and are committed to help us achieve this vision,” said Michael A. King, president and chief executive officer of Camden-Clark Memorial Hospital. “This initiative will equip our physicians with real-time access to up-to-date patient information and maximum clinical effectiveness. This investment also will improve each caregiver’s ability to make more informed decisions. The technology tools will enable a more collaborative, streamlined care environment across all our departments and disciplines. Most important, the patients and the community we serve will receive the ultimate benefit of improved healthcare for their lifetime.”

Key Solutions to Meeting Expected ARRA “Meaningful Use”

New technology solutions include Eclipsys’ leading computerized physician order entry (CPOE) system and other integrated clinical software solutions that document and automate care at the bedside, critical care units, laboratory, radiology department and the emergency room. An integrated pharmacy system will set the stage for closed loop medication administration processes and expedite more accurate handoffs between clinicians and pharmacist to reduce the chance for medication errors. To further support patient safety, Camden-Clark selected Eclipsys’ Knowledge-Based Medication Administration™ to help ensure the right patient receives the right medication via a handheld device caregivers will use to scan medication bar codes at the bedside. Web portal technology also will give Camden-Clark physicians secure, Internet access to patient information, such as test results and vital signs to enable quicker, more informed patient care decisions, regardless of whether the physician is at the hospital, home or office.

Finally, with Eclipsys’ Sunrise Patient Portal™, Camden-Clark plans to provide patients with self-service functionality, such as internet access to updated health information and ability to schedule doctor appointments. This level of patient connectivity and access to information is another facet providers must demonstrate to meet ARRA “Meaningful Use” requirements.

“After an extensive evaluation, we selected Eclipsys based on its accelerated implementation approach and proven track record in supporting clients in their efforts to reach deep levels of technology adoption— a key provision for ARRA incentives,” said Josh Woods, chief information officer of Camden-Clark Memorial Hospital. “Our strategic imperative is to be the preferred provider in the community we serve. These advanced technology tools will help us to achieve excellence in both our care practices and patient administrative services, which ultimately results in better patient outcomes and satisfaction. We are excited about the opportunity to work with Eclipsys to obtain their in-depth industry knowledge and business process expertise to support our healthcare mission and federal stimulus goals.”

Plans call for Camden-Clark to utilize Eclipsys’ “speed to value” implementation approach to accelerate the EHR activation. Eclipsys’ repeatable implementation methodology leverages the company’s rich client knowledge to provide more than 1,000 suggested design decisions to help reduce deployment cycle time and enable clients to focus on value-added activities during the implementation.

Connection with Allscripts EHR to Promote Continuity of Care

In a related clinical care initiative, Camden-Clark is in the process of connecting approximately 70 local affiliated and/or own physician practices with the Allscripts Professional EHR to support enhanced quality of patient care and improved patient communications. The patient information from Allscripts EHR will be connected to Camden-Clark’s acute care delivery environment using the Eclipsys HealthXchange, powered by Medicity. The seamless exchange of patient information between the physician offices and the hospital acute care setting will enhance continuity of care and supports both Camden-Clark and participating local physicians to qualify for ARRA funds.

Solution to Enhance Financial Workflow and Business Office Transformation

Camden-Clark also plans to deploy Eclipsys’ revenue cycle and front-end access management solutions to more-effectively manage the business aspects of the hospital. To further transform clinical and business operations, Eclipsys’ entire Enterprise Performance Management suite—Sunrise EPSi™, Sunrise Patient Flow™ and Sunrise Clinical Analytics™ will be used to significantly enhance the hospital’s strategic planning, operating budgeting and patient throughput processes, and more. In addition, Eclipsys’ Sunrise Clinical Analytics™ solution will be used to track and measure clinical performance to help the hospital improve quality, enhance medication safety and support the hospital’s ability to meet the Centers for Medicare & Medicaid Services (CMS) quality measures and Joint Commission standards.

“Eclipsys is committed to providing Camden-Clark Memorial Hospital with the strategic technology and implementation guidance to achieve its clinical and business goals,” said Jay Deady, executive vice president of Client Solutions at Eclipsys. “We are pleased that this new client has opted to take advantage of the unique and powerful combination of solutions and implementation services we can offer to community hospitals seeking to meet the ARRA meaningful use criteria and upgrade legacy revenue cycle solutions to meet the changing landscape of pay for quality. Our innovative implementation approach combines proven content along with workflow analysis and process-specific implementation methodology to help organizations achieve their technology goals in a shorter timeframe with fewer resources. We look forward to building a strong, long-standing relationship with this valued new client as they seek to provide the best possible care to its community.”

About Camden-Clark Memorial Hospital

Camden-Clark Memorial Hospital serves the mid-Ohio Valley and surrounding region through a 248-bed, not-for-profit, acute care facility with a 25-bed skilled nursing unit. It provides a broad range of services, offering the latest in medical technology and a highly trained staff. As the community's hospital for more than a century, Camden-Clark maintains a leadership role as the region’s primary source for advanced health care and wellness programs and has earned accreditation from The Joint Commission. For more information, see www.ccmh.org.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the implementation of and features and benefits provided by Eclipsys software, ARRA qualification, receipt of stimulus funds, and other results sought by Camden-Clark, evidence-based content and services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and client-specific configuration of Eclipsys software can be complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. ARRA qualification requires compliance with standards that are still evolving, and satisfaction of those standards may be delayed. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys, The Outcomes Company, Sunrise Enterprise, Knowledge-Based Charting, Knowledge-Based Medication Administration, Sunrise Pharmacy, Sunrise Clinical Analytics and Sunrise Critical Care are either registered trademarks or trademarks of Eclipsys Corporation (or its subsidiaries) in the United States and certain other countries. Other product and company names in this news release are or may be trademarks of their respective companies.

Eclipsys Corp. (MM) (NASDAQ:ECLP)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025

Eclipsys Corp. (MM) (NASDAQ:ECLP)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025